Promius Pharma Launches New Physician Portal to Track Patient Progress on Zenatane

July 15, 2014

A new web-based provider portal from Promius Pharma allows physicians to follow a patient's progress while taking Zenatane™(isotretinoin capsules USP) AB rated to Accutane. Designed to allow any authorized prescriber using the Promius Promise to obtain easy, instant access to secure patient data related to their prescriptions handled by the Promius Promise, the portal is HIPAA-secured.
The portal provides:
• A list of all patients who are enrolled in the Promius Promise program (when processed through Direct Success Pharmacy)
• Patient demographics
• Dates of prescriptions received
• Dates of prescription shipments
• Information on pending prescriptions
• Reports showing communication with the patients and HCP office to allow the patient to receive isotretinoin within the iPledge® Do Not Dispense window
• Messaging tool allowing HCP office to send questions and receive responses within the portal itself or on their smart phone devices as preferred
When treating patients with severe recalcitrant nodular acne, many physicians want to help ensure patient success by measuring compliance with treatment requirements. “Dermatologists told us this portal would be a valuable tool to help track a patient's adherence to guidelines, set by the FDA, for the use of isotretinoin. Hoping for the best outcome for their patients who are using Zenatane, this portal reflects back valuable information that can help enhance a patient's compliance,” explained Victor Caliman, Senior Brand Manager for Promius Pharma. “It reveals only information already submitted by the patient and Direct Success Pharmacy, thereby maintaining the strictest patient privacy as described by HIPPA.”

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free